Foxp3ϩ T regulatory cells are required to prevent autoimmune disease, but also prevent clearance of some chronic infections. While natural T regulatory cells are produced in the thymus, TGF-␤1 signaling combined with T-cell receptor signaling induces the expression of Foxp3 in CD4ϩ T cells in the periphery. We found that ICAM-1Ϫ/Ϫ mice have fewer T regulatory cells in the periphery than WT controls, due to a role for ICAM-1 in induction of Foxp3 expression in response to TGF-␤1. Further investigation revealed a functional deficiency in the TGF-␤1-induced translocation of phosphorylated Smad3 from the cytoplasmic compartment to the nucleus in ICAM-1-deficient mice. This impairment in the TGF-␤1 signaling pathway is most likely responsible for the decrease in T regulatory cell induction in the absence of ICAM-1. We hypothesized that in the presence of an inflammatory response, reduced production of inducible T regulatory cells would be evident in ICAM-1Ϫ/Ϫ mice. Indeed, following Mycobacterium tuberculosis infection, ICAM-1Ϫ/Ϫ mice had a pronounced reduction in T regulatory cells in the lungs compared with control mice. Consequently, the effector T-cell response and inflammation were greater in the lungs of ICAM-1Ϫ/Ϫ mice, resulting in morbidity due to overwhelming pathology.
Introduction
T regulatory cells play a key role in suppressing autoimmunity [1] . During chronic infections with pathogens, such as Leishmania major and Helicobacter pylori, T regulatory cell function inhibits pathogen clearance and dampens the immune response [2] [3] [4] ; thus, these cells are partially responsible for persistence of certain pathogens. CD4ϩ T regulatory cells are identified most reliably by expression of Foxp3 [5] [6] [7] but were originally identified by high expression of CD25. Natural CD4ϩCD25ϩFoxp3ϩ T regulatory cells are produced in the thymus. A very strong T-cell receptor signaling response could turn a developing T cell down the path to become a T regulatory cell [8] , and it has been suggested that these cells play a strong role in control over autoimmunity due to thymic expression of self-antigens [9] . Naïve CD4ϩ T cells in the periphery can also become Foxp3ϩ through T-cell receptor stimulation in conjunction with activated TGF-␤1 cytokine in vitro and in vivo [10 -14] . Inducible T regulatory cells have suppressive functions in response to specific non-self-antigens [10, 11, 14] . Since natural and TGF-␤1-induced T regulatory cells have the same phenotype in vivo during an inflammatory response (CD4ϩCD25ϩFoxp3ϩ), it is difficult to discriminate between the roles of these two phenotypes or whether it is natural or inducible T regulatory cells that inhibit pathogen clearance.
The role of T regulatory cells during Mycobacterium tuberculosis infection has been investigated previously. Depletion of CD4ϩCD25ϩ T cells ex vivo increased human and murine effector T-cell production of IFN-␥, a proinflammatory cytokine required for control over M. tuberculosis infection [15] [16] [17] , supporting a suppressive role for T regulatory cells in tuberculosis. While in vivo depletion of CD25ϩ cells in M. tuberculosis-infected mice did not reduce bacterial burden [17] , specific depletion of Foxp3ϩ cells or reconstitution of RAGϪ/Ϫ mice with leukocytes lacking CD4ϩCD25ϩ cells did improve control of infection [18, 19] . Thus, the available data support that, as in other infectious diseases, T reg-ulatory cells dampen the immune response to M. tuberculosis infection and inhibit clearance of the infection. However, another role for regulatory T cells may be the inhibition of inflammatory responses and subsequent pathology associated with infections.
The intercellular adhesion molecule-1 (ICAM-1), expressed not only on endothelium but also on leukocytes, can mediate extravasation of leukocytes into the lung [20] . ICAM-1 binding to LFA-1 allows T cells to adhere to thymic stroma during development [21] and assists in thymic positive selection of CD4ϩ or CD8ϩ T lymphocytes [21, 22] . ICAM-1 can also be found in association with LFA-1 at the immunological synapse [23] [24] [25] and transmits costimulatory signals to T lymphocytes [26 -30] . Sakaguchi and colleagues reported in a review article (as unpublished data) that ICAM-1-deficient mice develop fewer T regulatory cells in the periphery than controls [31] , but the etiology of the deficiency has not completely examined. It has been shown that ICAM-1Ϫ/Ϫ CD4ϩCD25ϩ T cells adoptively transferred into mice immunized with MOG peptide [which induces experimental autoimmune encephalomyelitis (EAE)] could depress proliferation of T cells specific for MOG peptide, but like wild-type (WT) T regulatory cells, they could not prevent onset of EAE [32] . As the expression of Foxp3 was not assessed in adoptively transferred CD4ϩCD25ϩ T cells and the number of T regulatory cells from ICAM-1Ϫ/Ϫ and WT mice was not compared, the role of ICAM-1 in T regulatory cell development and function has yet to be established.
Two studies addressing the role of ICAM-1 in M. tuberculosis infection gave conflicting results. One study reported that mice required ICAM-1 to form granulomas, with higher bacterial burdens and lower survival in ICAM-1Ϫ/Ϫ mice [33] . Another study indicated that ICAM-1 is not required for survival of mycobacterial infection [34] . Deficiency in the LFA-1 ICAM-1 ligand results in decreased T-cell priming, and aberrant granuloma formation [35] , while another ligand for ICAM-1, Mac-1 (CD11b/CD18), is not required to control M. tuberculosis [35] . The immunologic function of ICAM-1 during M. tuberculosis infection, thus, remains unclear.
In this study, we investigated the role of ICAM-1 in the production of T regulatory cells. In spite of similar Foxp3 expression in the thymus, ICAM-1Ϫ/Ϫ mice had significantly fewer T regulatory cells in peripheral organs such as the lung and spleen. Further investigation showed that ICAM-1 is required for the induction of CD4ϩCD25ϩFoxp3ϩ T regulatory cells in response to active TGF-␤1 and T-cell receptor stimulation and that this was due to a functional defect in the TGF-␤1 signaling pathway. In response to low-dose aerosol Mycobacterium tuberculosis infection, the deficit in expression of Foxp3ϩ T regulatory cells in ICAM-1Ϫ/Ϫ mice resulted in a more robust effector T lymphocyte response and greater inflammation compared with control mice. During high-dose M. tuberculosis infection, inflammation became overwhelming, and ICAM-1Ϫ/Ϫ mice became moribund more rapidly than wild-type mice, in spite of having a bacterial burden below that usually considered lethal.
MATERIALS AND METHODS

Animals
Breeding pairs of B6.129S4-ICAM-1 tm1jcgr /J (Generation N10F21) (ICAM-1Ϫ/Ϫ) mice were obtained from Jackson Laboratory (Bar Harbor, ME, USA). ICAM-1Ϫ/Ϫ (Generation N10F21) and control mice (Jackson Laboratory) were housed in a BioSafety Level 3 specific pathogen-free facility and monitored for murine pathogens. All animal protocols were approved by the University of Pittsburgh Institutional Animal Care and Use Committee.
Mycobacteria and infection of mice
Low-dose aerosol infection of mice (20 -100 colony forming units) of M. tuberculosis strain Erdman (Trudeau Institute, Saranac Lake, NY) has been described previously [36] . The bacterial burden was determined as described previously [37] .
Chemicals and reagents
All chemicals were purchased from Sigma-Aldrich (St. Louis, MO, USA) unless otherwise noted. Middlebrook 7H10 agar and 7H9 liquid media for growth of M. tuberculosis were purchased from Difco (Detroit, MI, USA).
IFN-␥ detection by ELISpot
Expression of IFN-␥ was determined by the ELISpot assay, performed as described previously [38, 39] , using bone marrow-derived dendritic cells infected with M. tuberculosis (MOI 3) for stimulation of lung and lymph node cells.
Production of bone marrow-derived antigen-presenting cells
In vivo migration assays and adoptive transfer of T regulatory cells
CD4ϩCD25ϩ T lymphocytes from M. tuberculosis infected ICAM-1Ϫ/Ϫ and WT spleens were separated with MACS Regulatory T cell Isolation kit (Miltenyi Biotec, Auburn, CA, USA) following the manufacturer's protocol. For adoptive transfer, 8ϫ10 6 T regulatory cells were intravenously injected into recipient ICAM-1Ϫ/Ϫ or WT mice. T regulatory cells for migration assays were counted, labeled using PKH26 (red, ICAM-1Ϫ/Ϫ) or PKH67 (green, WT) (Sigma-Aldrich, St. Louis, MO), and combined in a 1:1 ratio (ICAM-1Ϫ/Ϫ:WT). Eighteen-hour postintravenous injection of donor cells, lung perfusion, and bronchoalveolar lavage (BAL) were performed on M. tuberculosis-infected ICAM-1Ϫ/Ϫ and WT mice (following euthanasia). Tissue from the lung, liver, lymph nodes, and spleen was used for flow cytometry.
In vivo survival assays
CD4ϩ and CD8ϩ T lymphocytes were enriched using MACS beads (Miltenyi Biotec). WT or ICAM-1Ϫ/Ϫ T lymphocytes were combined in a 1:1 ratio with WT or ICAM-1Ϫ/Ϫ non-T lymphocytes and incubated with 30 units/ml IL-2 (Peprotec, Rocky Hill, NJ, USA). At predetermined time points, cells were collected for flow cytometry.
In vitro induction of Foxp3 expression in CD4؉CD25-T cells
CD4ϩCD25-splenocytes were separated from naïve ICAM-1Ϫ/Ϫ or WT spleens using MACS CD4ϩCD25ϩ regulatory T-cell isolation kit (Miltenyi Biotech). Enriched T cells were incubated at 37°C for up to 72 h with 100 U/ml IL-2 (PeproTech), 5 ng/ml active TGF-␤1 (R&D Systems, Minneapolis, MN, USA), anti-CD3 and anti-CD28 antibodies (BD PharMingen, San Jose, CA, USA) in a protocol adapted from those described previously by other groups [12, 14, 15, 42] . At predetermined time points, aliquots of T cells were taken for flow cytometry staining or immunoblotting. To add back ICAM-1, 12 g/ml ICAM-1-Fc chimera (R&D Systems), was added to ICAM-1Ϫ/Ϫ cultures.
Cell lysates for immunoblots
Smads and ␤-actin were detected by immunoblotting. Collected lymphocytes were counted using Trypan blue exclusion and lysed in cell lysis buffer (Tris, 1 NaCl, EDTA, NP-40) for 10 min on ice with phosphatase and protease inhibitors: leupeptin, aprotinin, pepstatin A, AEBSF, ␤-GLP, and orthvan. Cell lysates were centrifuged at high speed for 10 min. The supernatant (cytoplasmic extract) was removed from the pellet (nuclear extract). Sample running buffer (Tris-Cl, SDS, glycerol, DTT, bromophenol blue) was added to each sample, and boiled for 5 min prior to loading on the gel.
Immunoblotting
Cell lysates were loaded on a 10% acrylamide mini-gel next to Bio-Rad Precision Protein Dual Color Standard (Bio-Rad, Hercules, CA, USA). Proteins were wet transferred onto a 0.4-m PVDF membrane (Pall Life Sciences, East Hills, NY, USA) in tris-glycine-methanol buffer. Membranes were blocked in 4% bovine serum albumin. Primary antibody against specific Smads or ␤-actin (Cell Signaling Technology, Boston, MA, USA) were diluted in 4% bovine serum albumin in TBS/Tween 20 and incubated at 4°C overnight. After washing the immunoblot, we incubated the secondary antibody conjugated to HRP at room temperature for at least 1 h. Bands were visualized using SuperSignal West Pico chemiluminescent substrate (Thermo Scientific, Rockford, IL, USA), according to the manufacturer instructions, and images were captured and quantified using a Kodak Image station.
Immunoprecipitation
Specific monoclonal antibody against Smad4 (Abcam, Cambridge, MA, USA) and L-Sepharose beads (Fisher Scientific, Pittsburgh, PA, USA) were added to nuclear or cytoplasmic lysates rocked at 4°C overnight. The following morning, beads were centrifuged out of solution, and the supernatant was removed. Western blot sample running buffer was added to the beads to detach them from antibody, and beads were centrifuged out of solution. Samples were then analyzed by immunoblotting.
Statistical analysis
Statistical significance between two groups was compared by a two-sided Student's t test when data were normally distributed. Bacterial burden was normalized by log transformation prior to statistical analysis. A value of P Ͻ 0.05 was considered significant. Experiments were repeated to demonstrate reproducibility.
RESULTS
Fewer Foxp3؉ T regulatory cells are in the periphery of ICAM-1؊/؊ mice
A review suggested that fewer T regulatory cells could be found in the absence of ICAM-1 expression [31] , but the supporting data were not published. To explore whether ICAM-1 is required for production of T regulatory cells, the presence of Foxp3ϩCD4ϩ T regulatory cells was assessed by flow cytometry in the periphery of C57BL/6 ICAM-1Ϫ/Ϫ and wild-type (WT) control mice (Fig. 1A) . Significantly fewer Foxp3ϩ T regulatory cells were detected in the lungs and spleens of ICAM-1Ϫ/Ϫ mice compared with WT controls. In contrast, in the thymi of ICAM-1Ϫ/Ϫ and WT mice, Foxp3 expression was similar, suggesting that ICAM-1 is not required for thymic production of T regulatory cells.
ICAM-1 might play several roles in localizing T regulatory cells in peripheral organs. First, because both ICAM-1 and its lymphocyte ligand, LFA-1 can produce internal signals that cause proliferation, apoptosis, or costimulation [26 -30] , ICAM-1 ligation may be a required survival in the T regulatory cell. Next, ICAM-1 might be required for firm adhesion that allows migration of T regulatory cells into the peripheral organs. ICAM-1 may also provide a signal supporting proliferation of T regulatory cells. Finally, although natural T regulatory cells are produced equivalently in the thymi of ICAM-1Ϫ/Ϫ and control mice, ICAM-1 might be required to produce inducible T regulatory cells in the periphery.
ICAM-1 is not required for the survival of T regulatory cells
To test the hypothesis that ICAM-1 is required to send survival signals to regulatory T cells, flow cytometry staining of activated caspase 3 was used as a marker for apoptosis. Apoptosis of Foxp3ϩ T regulatory cells in the thymi of ICAM-1Ϫ/Ϫ and WT mice was similar (Fig. 1B) , suggesting that ICAM-1 is not required for natural T regulatory cells to survive within the thymus. Foxp3ϩ T regulatory cells in the lungs and in the spleens of ICAM-1Ϫ/Ϫ and WT mice showed similar percentages of activated caspase 3ϩ cells within the Foxp3 population (Fig. 1B) , suggesting that Foxp3ϩ T regulatory cells do not require ICAM-1 ligation to survive.
To confirm that ICAM-1 is not required for survival of T regulatory cells in the periphery, an in vivo T regulatory cell survival assay was performed by injecting congenic marker dis-crepant T regulatory cells into recipients and comparing survival of ICAM-1Ϫ/Ϫ and WT cells. Thy1.2ϩCD4ϩCD25ϩ T regulatory cells were enriched from ICAM-1Ϫ/Ϫ and WT controls. 5ϫ10 6 T regulatory cells were adoptively transferred into WT Thy1.1ϩ recipients. Two weeks following transfer, lungs and spleens of Thy1.1 recipients were harvested, and the survival of injected ICAM-1Ϫ/Ϫ or WT T regulatory cells was assessed. Similar percentages of input Thy1.2ϩ donor T regulatory cells were detected in the lungs and spleens of WT recipients (Fig. 1C) , confirming that ICAM-1 is not required on T regulatory cells for their survival in the periphery.
ICAM-1 is not required for the migration of T regulatory cells in the periphery
T regulatory cells could be dependent on ICAM-1 for migration in the periphery. To test this hypothesis, we used an antigen-specific system to follow the migration of T regulatory cells into the tissues during an inflammatory response. ICAM-1Ϫ/Ϫ or WT mice were infected with M. tuberculosis for at least 4 wk. CD4ϩCD25ϩ T regulatory cells from infected ICAM-1Ϫ/Ϫ or WT spleens were enriched using MACS columns. To observe migration of T regulatory cells, ICAM-1Ϫ/Ϫ and WT CD4ϩCD25ϩ T cells were differentially labeled red (PKH26) or green (PKH67), combined in equal numbers and adoptively transferred into recipients that had been infected with M. tuberculosis for at least 4 wk. In this way, each recipient received equal numbers of adoptively transferred ICAM-1Ϫ/Ϫ and WT cells, and their migration could be directly compared. Donor CD4ϩCD25ϩ T cells were allowed to migrate for 18 h, at which point, recipient organs were harvested to assess the migration of ICAM-1Ϫ/Ϫ and WT T regulatory cells. Figure  2A shows representative dot plots of flow cytometry detection of labeled T regulatory cells in recipient lungs. Although it appeared that fewer ICAM-1Ϫ/Ϫ T regulatory cells migrated into ICAM-1Ϫ/Ϫ lungs when comparing dot plots, the differences were not statistically significant by Student's t test, even when 15 mice per group were compared (Fig. 1A and data not shown). WT T regulatory cells were equally capable of migrating into the lungs (Fig. 2B ) and spleens (data not shown) of ICAM-1Ϫ/Ϫ and WT recipient mice, suggesting that ICAM-1 expression is not required on the endothelium in order for T regulatory cells to migrate into infected tissues. Similar percentages of ICAM-1Ϫ/Ϫ and WT T regulatory cells were detected in the lungs (Fig. 2C ) and spleens (data not shown) of WT mice, suggesting that ICAM-1 is not required on the T regulatory cell for the migration to tissues from the periphery. Similar experiments performed with total CD4 T cell populations demonstrated that ICAM-1 expression on T cells or endothelium was not required for normal migration of cells into the lungs of infected mice, nor was there an increase in migration into ICAM1Ϫ/Ϫ lungs of total CD4 T cells (data not shown).
Induction of regulatory T cells by TGF-␤1 partially requires ICAM-1 expression
Foxp3 expression that results in functional T regulatory cells can be induced in peripheral CD4ϩ T cells by TGF-␤1 stimulation in vitro [12, 14, 43] and in vivo [11, 13] . To determine whether ICAM-1 is required to induce Foxp3 expression, CD4ϩCD25-(non-T regulatory) cells were enriched from naïve ICAM-1Ϫ/Ϫ or WT spleens using MACS columns. It is possible that Foxp3ϩ T regulatory cells could be CD25 low, allow- ing some T regulatory cells to be present in these cultures. However, flow cytometry analysis of Foxp3 expression after enrichment showed no expression of Foxp3 in CD4ϩCD25-T cells (Fig. 3A , time 0 and Supplemental Fig. 1 ), supporting that the vast majority of T regulatory cells had been removed with this treatment. CD4ϩCD25-T cells were incubated for up to 72 h with recombinant active TGF-␤1, IL-2, anti-CD3, and anti-CD28 antibodies, as described by others as a method of inducing T regulatory cells [12, 14, 15, 42] . CD25 expression was up-regulated on 100% of ICAM-1Ϫ/Ϫ and WT T cells by 48 h of incubation and maintained through 72 h (data not shown). After 72 h, Foxp3 expression was detected in significantly fewer ICAM-1Ϫ/Ϫ CD4ϩ T cells compared with WT ( Fig. 3A and Supplemental Fig. 1) , suggesting a functional difference between ICAM-1Ϫ/Ϫ and WT CD4ϩ T cells in their ability to respond to TGF-␤1. The addition of soluble ICAM-1-Fc recovered Foxp3 induction, supporting a role for ICAM-1 in Foxp3 induction (Fig. 3A) .
To confirm that ICAM-1Ϫ/Ϫ and WT-inducible T regulatory cells were functionally active, we collected activated leukocytes from the lungs of M. tuberculosis-infected mice. Lung leukocytes were added to an IFN-␥ ELISpot, in which bone marrow derived dendritic cells presented M. tuberculosis antigens. Inducible T regulatory cells were added in a 1:1 ratio with lung leukocytes to determine whether IFN-␥ production could be suppressed by inducible T regulatory cells. IFN-␥ production by WT T cells from M. tuberculosis-infected mice was suppressed by both ICAM-1Ϫ/Ϫ and WT T regulatory cells (Supplemental Fig. 2) .
Active TGF-␤1 interacts with TGF-␤RII, which phosphorylates TGF-␤RI. In turn, TGF-␤R1 recruits and phosphorylates Smads [44, 45] that translocate to the nucleus to act as transcription factors [46] . To assess whether TGF-␤1 signaling was equivalent in ICAM-1Ϫ/Ϫ and WT CD4ϩ T cells, phosphorylation and translocation of Smad2 and Smad3 was compared by immunoblotting. Protein was collected from the cytoplasmic and nuclear fractions of T cells in the in vitro culture system described above, with representative blots shown in Fig.  3B . Early expression of phosphorylated Smad2 during TGF-␤1 stimulation was similar in ICAM-1Ϫ/Ϫ and WT T cells (data not shown). ICAM-1Ϫ/Ϫ and WT T cells also had similar levels of total Smad3 protein prior to treatment with TGF-␤1 (data not shown), and similar levels of phosphorylated Smad3 (pSmad3) were detected in the cytoplasm of ICAM-1Ϫ/Ϫ and WT CD4ϩ T cells during in vitro culture (Fig. 3C) . However, significantly more pSmad3 was detected in the nucleus of WT CD4ϩ T cells compared with ICAM-1Ϫ/Ϫ CD4ϩ T cells (Fig. 3D ). More total pSmad3 (determined by adding relative nuclear and cytoplasmic expression in immunoblots, and by flow cytometry) was seen in WT compared with ICAM-1Ϫ/Ϫ CD4ϩ T cells (Fig. 3E) . The addition of soluble ICAM-1-Fc to ICAM-1Ϫ/Ϫ CD4ϩ T cells resulted in a significant increase in pSmad3 (Fig. 3E ), which correlated with recovery of WT levels of Foxp3 expression. In WT CD4ϩ T cells, the relative ratio of pSmad3 in the nucleus compared with the cytoplasm was higher than in ICAM-1Ϫ/Ϫ CD4ϩ T cells (Fig. 3F) , supporting that there is a defect in translocation of pSmad3 into the nucleus of ICAM-1Ϫ/Ϫ T cells.
Optimal translocation of pSmad3 in association with Smad4 requires ICAM-1
The requirement of ICAM-1 in translocation of pSmad3 from the cytoplasm into the nucleus was surprising. After being phosphorylated, Smad transcription factors associate with Smad4, a Smad shuttle protein that facilitates movement from the cytoplasm into the nucleus (reviewed in [47] ). We hypothesized that ICAM-1 might be required for association of pSmad3 with Smad4 following phosphorylation, so that ICAM-1 deficiency prevents pSmad3 from binding to Smad4, causing pSmad3 to remain in the cytoplasm. To test this hypothesis, Smad4 was immunoprecipitated from cytoplasmic and nuclear cell lysates, and coimmunoprecipitation of pSmad3 was assessed by immunoblotting. Representative immunoblots are shown in Fig. 4A . The mean intensity of the detected ICAM-1Ϫ/Ϫ pSmad3 bands was much lower than pSmad3 from WT T cells in the nucleus (Fig. 4B) , while similar pSmad3 was detected in ICAM-1Ϫ/Ϫ and WT cytoplasmic immunoprecipitates (Fig. 4C ). pSmad3 in nuclear or cytoplasmic lysates was normalized to Smad4 in immunoprecipitates, and this ratio supported a greater detection of pSmad3 in the nuclear lysastes of WT cells, while similar levels of pSmad3 could be detected in the cytoplasm (Fig. 4D) . This suggested ICAM-1 may play a role in pSmad3 translocation downstream of its association of Smad4.
ICAM-1؊/؊ T regulatory cell deficit results in more severe inflammation
We hypothesized that during an inflammatory response, there would be a more pronounced difference due to the ICAM-1Ϫ/Ϫ defect in induction of Foxp3 in CD4 T cells. To test this, ICAM-1Ϫ/Ϫ and WT mice were infected with M. tuberculosis (either ϳ25 or ϳ100 colony forming units). After 7 wk of infection, the total number of Foxp3ϩ T regulatory cells in- creased in both WT and ICAM-1Ϫ/Ϫ mice, but there were significantly fewer T regulatory cells in the lungs of ICAM-1Ϫ/Ϫ mice than in WT lungs by 7 wk postinfection, which is the beginning of the chronic phase of infection (Fig. 5A) . At this time point, Foxp3ϩ T regulatory cells in the lungs of WT mice represented 7.26 Ϯ 1.06% of CD4ϩ T cells, while Foxp3ϩ T regulatory cells in ICAM-1Ϫ/Ϫ mice represented only 3.09% Ϯ 0.89% of CD4ϩ T cells (PϽ0.0001). We hypothesized that ICAM-1 signals proliferation of T regulatory cells during an inflammatory response to account for the reduction in T regulatory cells in ICAM-1Ϫ/Ϫ mice. However, experiments throughout acute and chronic infection comparing expression of cell cycle antigen KI67 and lymphocyte proliferation assays early in infection indicated that there was no difference in the proliferation of T regulatory cells during M. tuberculosis infection (data not shown).
Recent studies suggest that in the absence of T regulatory cells, the cytokine response to M. tuberculosis is enhanced [15, [17] [18] [19] 48] , and bacterial control is improved [18, 19] . There was no difference in survival of ICAM-1Ϫ/Ϫ and WT mice infected with ϳ25 CFU of M. tuberculosis (both strains survived more than a year postinfection), and bacterial numbers in the lungs were similar over the course of infection (Fig. 5B) . Histological examination of the lungs of ICAM-1Ϫ/Ϫ and WT mice infected with M. tuberculosis revealed that organized granulomas were detectable in the lungs by 4 wk postinfection (Fig. 6A) . However, after 16 wk of infection, lung infiltration appeared much higher by histological observation in ICAM-1Ϫ/Ϫ animals than controls (Fig. 6B) . Computational comparison of the available airspace in random histological samples revealed that ICAM-1Ϫ/Ϫ mice had significantly less airspace available than WT mice (PϽ0.0001) (Fig. 6C) , suggesting that the higher lung infiltrate compromised lung capacity in ICAM-1Ϫ/Ϫ mice.
In light of previous publications [33, 34] in which ICAM-1Ϫ/Ϫ mice were more susceptible to M. tuberculosis infection, we infected ICAM-1Ϫ/Ϫ and WT mice with a higher dose of infection (ϳ100 CFU), and followed survival. ICAM-1Ϫ/Ϫ mice began to succumb to infection by 14 wk postinfection (Fig. 5C ). Further investigation revealed that while bacterial burden was slightly higher in ICAM-1Ϫ/Ϫ mice than WT mice (ϳ5 fold in the lungs) (Fig. 5D) , it was not at a level that is usually fatal. Histological examination revealed substantially greater inflammation and pathology in the lungs of ICAM-1Ϫ/Ϫ, compared with WT mice. The lack of effector T-cell regulation in lungs of ICAM-1Ϫ/Ϫ mice likely contributed to overwhelming inflammation and increased morbidity in the absence of ICAM-1.
Flow cytometry analysis confirmed that significantly higher numbers of CD4ϩ and CD8ϩ T lymphocytes were present in the lungs of ICAM-1Ϫ/Ϫ mice infected with both doses of M. tuberculosis beginning ϳ7 wk postinfection (Fig. 7, A and B) . Interestingly, levels of CD4ϩFoxp3-T cells tended to be higher in naïve ICAM-1Ϫ/Ϫ lungs and spleen compared with WT (data not shown). Overall, in the ICAM-1Ϫ/Ϫ mice in organs where fewer T regulatory cells were present, more nonregulatory CD4ϩ T cells could be detected, both in naïve mice, and during M. tuberculosis infection, suggesting that Foxp3ϩ T regulatory cells are required to maintain T-cell homeostasis.
The increased numbers of T cells in the lungs of ICAM-1Ϫ/Ϫ mice accordingly led to higher IFN-␥ production 7 wk postinfection in an ELISpot assay (data not shown). Flow cytometry confirmed that the percentage of CD4ϩ and CD8ϩ T cells producing IFN-␥ were similar, but the numbers of these cells in ICAM-1Ϫ/Ϫ lungs were increased (data not shown). At all time points, lung-infiltrating macrophages, neutrophils, and dendritic cells were equivalent between ICAM-1Ϫ/Ϫ and control mice (data not shown). No differences in any cell populations were detected in the lung draining lymph nodes (data not shown), suggesting that similar numbers of T lymphocytes were produced in the secondary lymphoid organs.
ICAM-1 may be required for T lymphocyte apoptosis in the lungs of M. tuberculosis infected mice
As similar T-cell populations were detected in the lymph nodes of ICAM-1Ϫ/Ϫ and control mice (data not shown), differences in priming the total CD4ϩ and CD8ϩ lymphocyte population is unlikely. Increased effector T lymphocytes detected in ICAM-1Ϫ/Ϫ lungs could be due to greater proliferation or decreased apoptosis. Expression of the nuclear antigen Ki67 was used to compare proliferation of T lymphocytes in the lungs of M. tuberculosis-infected mice by flow cytometry; there was no difference in proliferation of ICAM-1Ϫ/Ϫ and WT lung T cells (data not shown). A significant decrease in ICAM-1Ϫ/Ϫ T lymphocyte apoptosis was consistently detected 7 wk postinfection ICAM-1Ϫ/Ϫ lungs (Fig. 7C) , detected by Annexin V staining and confirmed by activated caspase 3 staining (data not shown). These data suggest that optimal contraction of the effector T lymphocyte population in the lungs during M. tuberculosis infection requires ICAM-1 expression. Alternatively, the decrease in apoptosis of effector T cells may be due to the increased inflammation in the absence of T regulatory cells, instead of by a direct T regulatory cell-mediated mechanism.
Adoptive transfer of naïve CD4؉ CD25؉ T regulatory cells prior to M. tuberculosis infection decreases total effector T cells in the lungs over time
In naïve and M. tuberculosis-infected ICAM-1Ϫ/Ϫ mice, fewer T regulatory cells are present than in WT mice (Fig. 1) . The total number of T lymphocytes in naïve spleen and M. tuberculosis-infected lung was also higher in ICAM-1Ϫ/Ϫ mice com- pared with WT mice (data not shown). To determine whether these phenotypes are related, naïve CD4ϩCD25ϩ T cells were enriched from WT spleens (99% were also Foxp3ϩ) and adoptively transferred into ICAM-1Ϫ/Ϫ or WT mice one day prior to M. tuberculosis infection. We hypothesized supplemental WT CD4ϩCD25ϩ T cells would decrease the ICAM-1Ϫ/Ϫ adaptive response to M. tuberculosis infection. At 7 wk postinfection, the total number of CD4ϩ (Fig. 7D ) and CD8ϩ (data not shown) T cells in lungs of ICAM1Ϫ/Ϫ mice that received WT CD4ϩCD25ϩ cells was reduced significantly compared with nonrecipient ICAM-1Ϫ/Ϫ mice. In addition, the inflammation of the lungs was markedly reduced in ICAM-1Ϫ/Ϫ mice adoptively transferred with WT CD4ϩCD25ϩ T cells (Fig. 8) . Analysis of available airspace showed that ICAM-1Ϫ/Ϫ mice had significantly increased available airspace (49.02Ϯ5.49%) compared with ICAM-1Ϫ/Ϫ mice that did not receive adoptive transfers (38.73Ϯ8.06) (PϽ0.05). These data support that WT regulatory T cells complement the defect in ICAM-1Ϫ/Ϫ lungs, and restore normal T-cell and inflammatory responses to M. tuberculosis.
DISCUSSION
The data presented here demonstrate that ICAM-1 is required for the induction of Foxp3ϩ T regulatory cells in the periphery, which impacts T-cell homeostasis. The reduced responsiveness to TGF-␤1 signaling in ICAM-1-deficient CD4ϩ T cells resulted in impaired Foxp3 expression, and a subsequent reduction in T regulatory cells in the tissues of ICAM-1Ϫ/Ϫ mice. Reduction of T regulatory cells was more pronounced during an inflammatory response to Mycobacterium tuberculosis infection and was the cause of increased effector T lymphocytes in infected lungs, as addition of regulatory T cells to the ICAM1Ϫ/Ϫ mice restored normal numbers of T cells and reduced inflammation in the lungs. Rather than controlling proliferation, T regulatory cells may play a role in contraction of T lymphocytes, as apoptosis was reduced during the contraction phase of the immune response. Contrary to previous reports [33, 34] , in the absence of ICAM-1, granulomas formed in response to low-dose M. tuberculosis infection, allowing mice to control bacterial burden and survive equivalently to WT mice. However, in mice infected with a higher dose of M. tuberculosis, lung inflammation and pathology increased substantially late in infection, contributing to the decreased survival of ICAM1Ϫ/Ϫ mice. The data presented here support that the reduction in regulatory T cells in ICAM1Ϫ/Ϫ mice contributed to increased inflammation and pathology, and a worsened outcome in M. tuberculosis-infected mice. This suggests a previously unappreciated role for ICAM-1 in regulation of immune responses.
Although there was a significant reduction in T regulatory cells in peripheral organs in naïve ICAM-1Ϫ/Ϫ mice, similar expression of Foxp3 in the thymus of ICAM-1Ϫ/Ϫ and WT mice was observed, suggesting that thymic production of natural T regulatory cells does not require ICAM-1. CD4ϩCD25-splenocytes cultured in vitro had significantly reduced induction of Foxp3 in response to TGF-␤1 compared with WT cells, suggesting that postthymic induction of T regulatory cells is impaired in the absence of ICAM-1.
During M. tuberculosis infection in WT mice, Foxp3 expression increased into the chronic phase of infection. Foxp3 expression in ICAM-1Ϫ/Ϫ CD4ϩ T cells remained much lower in vitro and in vivo, which suggests that the same mechanism could be responsible for this deviation from WT responses. The expression of activated TGF-␤1 was very similar in the lungs and lymph nodes of ICAM-1Ϫ/Ϫ and WT mice throughout infection (data not shown), suggesting that it is the induction of Foxp3 that is defective in vivo, and not availability of active TGF-␤1. Although the phenotype of natural and inducible T regulatory cells in vivo is indistinguishable (CD4ϩ CD25ϩFoxp3ϩ), it seems more likely that inducible T regulatory cells are produced during the inflammatory response, rather than increased production of natural T regulatory cells. T regulatory cells may also be proliferating in vivo during M. tuberculosis infection, but Ki67 staining of T cells from lungs of ICAM-1Ϫ/Ϫ and WT mice was similar, supporting that de novo expression of Foxp3 in peripheral CD4ϩ T cells is responsible for increased T regulatory cell expression. Transferring additional T regulatory cells to ICAM-1Ϫ/Ϫ mice reduced the inflammation in the lungs during M. tuberculosis infection to wild-type levels, strongly implicating the reduction in T regulatory cells in the ICAM-1Ϫ/Ϫ mice as the responsible factor for increased numbers of lymphocytes in the lungs of these mice.
We have observed that during low dose M. tuberculosis infection in ICAM-1Ϫ/Ϫ mice, granuloma formation occurs with similar kinetics seen in WT mice. Bacterial burden was maintained at a similar level to WT, and ICAM-1Ϫ/Ϫ mice are able to survive low-dose M. tuberculosis infection equivalently. However, ICAM-1Ϫ/Ϫ mice succumb to higher-dose infection at ϳ14 wk, most likely because of the increased pathology observed in the lungs. Although LFA-1 deficiency resulted in insufficient granuloma formation due to decreased T lymphocyte priming [35] , ICAM-1Ϫ/Ϫ antigenpresenting cells clearly primed effector cells efficiently and mounted a sufficient immune response. The findings reported here show that ICAM-1 expression is not required to control M. tuberculosis infection, although it is involved in control of inflammation.
TGF-␤1 signaling requires transport of phosphorylated Smads into the nucleus, where transcription responses rely on prolonged TGF-␤-receptor signaling [49, 50] . TGF-␤1 induces Foxp3 expression requisite for CD4ϩCD25ϩ T regulatory cells [14] . In the absence of ICAM-1 expression, induction of Foxp3 through TGF-␤ receptor signaling was reduced. A defect in the TGF-␤ receptor signaling machinery caused reduced translocation of phosphorylated Smad3, but not phosphorylated Smad2, from the cytoplasm into the nucleus. These results complement findings in Cbl-b-deficient mice, in which Cbl-b was required for phosphorylation of Smad2, but not phosphorylated Smad3 [51] . Together, the findings reported here and previously suggest that regulation of TGF-␤1 signaling is mediated on several levels by molecules as diverse as ubiquitin ligases and adhesion molecules.
The relationship between ICAM-1 expression and TGF-␤ receptor signaling is not intuitive. ICAM-1 expression was not required for the association of phosphorylated Smad3 with Smad4, but it was required for the movement of pSmad3 (presumably complexed with Smad4) into the nucleus. This may indicate a requirement for signaling between ICAM-1 and LFA-1 during TGF-␤1 stimulation. The addition of soluble ICAM-1 to the in vitro cultures restored the ability of ICAM-1Ϫ/Ϫ cells to express Foxp3 (Fig. 3A) . The mechanism through which ICAM-1 plays a role in pSmad3 translocation into the nucleus has not been defined and is beyond the scope of this study. However, we can hypothesize the following. Although we were unable to detect ICAM-1 expression on the vast majority of WT T regulatory cells (data not shown), ICAM-1 shedding and/or secretion has been well documented [52] [53] [54] [55] and could play a role in LFA-1 ligation. Soluble ICAM-1 does not lose its ability to bind LFA-1 [52] , and, if present, could transmit a signal through LFA-1 on CD4ϩ T cells that assists in TGF-␤1 signaling. LFA-1 ligation activates actin polymerization [56] , myosin motor activity [57] , and rearrangement of the microtubule network [58, 59] . The microtubule network is responsible for controlling Smad localization in the cytoplasm, such that destabilization of microtubules allows the release of Smads into the nucleus [60] . The role of LFA-1 in rearranging the microtubule network might, therefore, allow phosphorylated Smads to be released from the cytoplasm into the nucleus. Loss of ICAM-1/LFA-1 interaction could inhibit cytoskeletal rearrangements required for translocation of nucleus-bound transcription factors, such as phosphorylated Smad3 from the cytoplasm. We attempted to test this hypothesis by comparing the rearrangement of the microtubule network by confocal microscopy but were unable to detect changes on the macroscopic level (data not shown). However, we cannot rule out this as the reason for the requirement of ICAM-1 for translocation of pSmad3 into the nucleus that is required for Foxp3 expression.
Further studies are required to investigate the role of ICAM-1/ LFA-1 signaling in microtubule reorganization that may allow translocation of transcription factors into the nucleus. It is of interest to determine whether it is only TGF-␤ receptor signaling that is affected by the absence of ICAM-1, or whether there are additional signaling pathways that are negatively affected by ICAM-1 deficiency. Finally, TGF-␤1 signaling may be impaired in somatic cells other than T lymphocytes, and this has not yet been investigated.
